Back to Markets
HEHelus Pharma

Helus Pharma

HELPAEQUITAS NEO EXCHANGE
Health CarePharmaceuticals

$4.55

+0.0600 (+1.34%)

As of 05/29/26 EDT · USD

Compare
Low: $4.15Current: $4.55High: $9.83

Key Statistics

Open

$4.49

Day High

$4.58

Day Low

$4.40

Prev. Close

$4.49

VolumeShares traded today.

369.93K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$227.66M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-1.26

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$9.83

52W LowLowest price over the past 52 weeks.

$4.15

50D MAAverage closing price over the last 50 trading days.

$5.01

200D MAAverage closing price over the last 200 trading days.

$6.19

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

-1.1%

1M

-7.3%

6M

-26.3%

YTD

-45.0%

1Y

-43.8%

About

Helus Pharma, also known formerly as Cybin IRL, is a Canadian pharmaceutical company that was led by CEO Doug Drysdale from 2020-2025, developing psychedelic drugs as medicines.

www.helus.com

Company Facts

SectorHealth Care
IndustryPharmaceuticals
ExchangeAEQUITAS NEO EXCHANGE
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade HELP

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.